Clinical Trials Browser

INDUSTRY × Neoplasms, Second Primary × Clear all

NCT06562647 2026-02-13

SY001 Targets Mesothelin in a Single-arm, Dose-increasing Setting in Subjects With Advanced Solid Tumors

Phase NA Recruiting

2 enrolled

Gynecologic

Ovarian Neoplasms, Neoplasms, Second Primary

NCT03098589 2025-03-30

Revlimid® Capsules Drug Use-results Surveillance (Relapsed or Refractory ATLL)

Completed

1,149 enrolled

Head & NeckLymphoidOther hematologic neoplasm

Sleepiness, Arrhythmias, Cardiac, Cataract, Confusion, Coronary Artery Disease, Digestive System Diseases, Dizziness, Fatigue, Heart Failure, Hemorrhage, Hypersensitivity, Hypotension, Orthostatic, Hypothyroidism, Infections, Lymphoma, Peripheral Nervous System Diseases, Seizures, Thromboembolism, Tumor Lysis Syndrome, Neoplasms, Second Primary, Lung Diseases, Interstitial, Renal Insufficiency, Precursor T-Cell Lymphoblastic Leukemia-Lymphoma, Teratogenesis

NCT05664009 2024-04-05

The Safety and Efficacy of Redsenol-1 Plus on Cancer-related Fatigue in Adults

Phase 2 Recruiting

72 enrolled

Fatigue, Neoplasms, Second Primary

NCT02741544 2022-06-21

Revlimid® Capsules Special Drug Use-results Survey (in Patients With Newly-diagnosed Multiple Myeloma [NDMM])

Completed

578 enrolled

Plasma cell

Cataract, Multiple Myeloma, Neoplasms, Second Primary

NCT00638963 2017-06-14

STOP

Phase 2 Terminated

6 enrolled 9 charts

BreastCNS

Brain Neoplasms, Breast Neoplasms, Neoplasms, Second Primary